Home / Transcripts / CRA International, Inc. (CRAI) · May 7, 2026

CRA International, Inc. (CRAI) Earnings Call Transcript

May 7, 2026

NASDAQ US Industrials Professional Services earnings 38 min

Earnings Call Speaker Segments

Eric Nierenberg executive
#1

Thanks, Rob, and hello everybody. I want to remind you that anything we say on this call — our guidance regarding future revenue and non-GAAP EBITDA margin, along with any other remarks about CRA's future business, operating results, or financial condition, such as those containing the words expect, outlook, or similar terms — constitutes forward-looking statements under Section 21E of the Exchange Act. What's contained in these forward-looking statements rests on management's current expectations and is inherently uncertain. Actual performance and results could differ materially from what these statements express or imply because of many important factors, among them the level of demand for our services stemming from shifts in general and industry-specific economic conditions. Further details about these factors appear in today's release and in CRA's periodic reports, including our most recently filed annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC. CRA assumes no obligation to update these forward-looking statements after the date of this call to reflect new information or developments. In addition, we will refer on this call to some non-GAAP financial measures and certain measures presented on a constant currency basis. We encourage everyone to refer to today's release and related CFO remarks for reconciliations of these non-GAAP financial measures to their GAAP comparable measures and descriptions of the calculation of EBITDA and measures presented on a constant currency basis. I'll now hand it over to Paul for his report. Paul?

Paul A. Maleh executive
#2

Thanks, Eric, and good morning, everyone. We appreciate you being with us today. CRA kept up its robust results as we moved into the first quarter of fiscal 2026, with revenue rising 10.5% compared with the same period a year earlier, reaching $201 million. That marks the largest quarterly revenue the company has ever recorded, surpassing the prior record held by the fourth quarter of fiscal 2025. The quarter's solid results came from contributions across the board, as eight practices achieved year-over-year growth. Four practices — Energy, Finance, Forensic Services, and Life Sciences — recorded double-digit revenue growth, while the Antitrust & Competition Economics practice reached a new quarterly revenue high. We saw expansion in every region we operate in: revenue for North America climbed 8.5%, while our business outside the U.S. posted a 20.3% increase compared with the same period last year. Companywide, the number of consultants we employ moved up 2.5% versus the first quarter of 2025. Utilization among consultants came in at 77% on a year-over-year basis, an improvement. Those advances in both consultant staffing levels and utilization were supported by a sales pipeline that keeps getting refilled. Both the average number of project leads per week and newly originated projects set quarterly records, and each grew by double digits relative to the first quarter of 2025. Our management of the business remained solid throughout the first quarter, generating $23.2 million in non-GAAP EBITDA, which works out to 11.5% of revenue. Just to note, the opening quarter tends to see an outsized hit from costs tied to employee benefits and taxes, since that's when yearly bonuses get paid out. Our Q1 EBITDA number also carries $13.8 million in non-cash amortization on forgivable loans, which works out to 6.9% of revenue. Versus a year earlier, that's up $4.8 million, or 53%, in line with what we anticipated and what we said previously when we set our annual profit outlook for FY 2026. Let me now spend a few minutes walking through the demand for our offerings and a handful of the engagements we completed in Q1. First-quarter revenue from CRA's legal and regulatory services climbed 11.5%. Our expansion here tracked what happened across the legal industry overall — total case filings climbed 8% and total court judgments climbed 13%, each measured against the first quarter of 2025. Now, on the M&A side, deal activity globally hit $1.2 trillion in the first quarter of 2026, which represents a 27% increase over the prior year. That figure makes it the best opening quarter for deal-making since 2021, and it's also the third quarter in a row above $1 trillion. Given those conditions, CRA's Antitrust & Competition Economics practice had a record quarter, benefiting from sustained merger-related work and steady appetite for antitrust services. This quarter, CRA's competition group was brought on jointly to advise on a merger involving two of North America's biggest distributors in the janitorial, sanitation, and food services space. The team examined how the deal might affect competition on a local basis and across a wide range of customer verticals. Drawing on the parties' sales and bidding data alongside industry and publicly available information, CRA put together and delivered several empirical analyses to the Federal Trade Commission, which ended with the agency granting unconditional clearance. Separately, a CRA competition team advised REEL International, a company that designs and builds industrial lifting and handling systems, in a damages lawsuit brought by a competitor, Fives ECL, before the Hamburg Local Division of the Unified Patent Court. ECL pursued compensation for profits it said it lost, alleging that infringement of a patent by REEL caused a price cut. CRA's team backed REEL with an expert report stressing how vital it is to evaluate the profits the claimants probably would have generated had no infringement occurred; the court threw out the claim entirely in February 2026. That ruling stands among the earliest Unified Patent Court decisions addressing causation analysis and damages quantification since the Pan-European Court began operations in 2023. Elsewhere, our Finance practice kept busy handling complex business disputes and probes that touch all of our focus areas, including M&A and corporate governance, bankruptcy, trading, securities, insurance, plus international arbitration. One example: a team of CRA consultants supported an expert witness who testified regarding damages arising from a food safety crisis during the first Caremark trial at the Delaware Court of Chancery, which concerned directors' fiduciary obligations to keep adequate information and reporting systems in place. In another engagement, a separate group supported a CRA expert who testified at trial about the distinction between excluded and participating lenders in the 2020 Serta Simmons Bedding liability management uptier transaction. During Q1, CRA's Forensic Services group took on hundreds of engagements. These spanned ransomware cases, wire transfer fraud, employee misconduct matters, trade secret disputes, and broader litigation work. To illustrate, we recently assisted a global software firm seeking confidence regarding whether a threat actor's activity had breached its software development environments, including core code bases. Our personnel conducted an in-depth forensic review of build systems alongside the orchestration infrastructure that oversees and manages the software development lifecycle, aiming to assess any potential tampering with code or the build process. Additionally, the practice is being engaged in assignments that position us at the center of unusually intricate and freshly arising data issues, particularly in the privacy and advertising technology arenas. As one instance, we are aiding one of the largest advertising technology firms globally as it defends a privacy class action concerning online tracking technologies. Our team completed a detailed analysis spanning a multi-terabyte data set, delivered a thorough expert report, and stands ready to offer expert testimony backing the client's defense at trial. Shifting to our management consulting services, the Energy and Life Sciences practice each achieved double-digit revenue growth. CRA's Energy practice assisted a broad range of clients during the year's first quarter, among them utilities, electric system operators, private equity, large energy customers, electric equipment manufacturers, and regulators. To illustrate, the practice counseled a utility client on its data center tariffs and its strategy for handling large loads so as to reduce risk to customers. In another instance, PJM, the Mid-Atlantic System Operator, engaged the practice to lead the prominent backstop procurement auction tied to rising loads amid data center expansion. Lastly, a private equity group brought us in to handle commercial and regulatory due diligence for a sizable community solar portfolio. Within our life sciences practice, we keep drawing on the team's strengths in strategy and policy consulting. Consider our engagement with a mid-sized worldwide pharma firm focused on immunology, for example. The group developed an in-depth plan intended for board-level evaluation, addressing avenues for expansion, how to price the offering, hurdles to market access, and pertinent policy matters. A distinct initiative focused on examining pricing globally for a fresh combination treatment containing a currently successful blockbuster in the cardiovascular and nephrology areas. That review covered North American, European, and Asian markets, paying particular heed to the Most Favored Nation pricing measures being put forward by the present U.S. administration. I want to thank all of my colleagues for the effort they put in during Q1 to help our clients address their toughest problems. We're pleased with the strength the business showed at the start of the year, and we'll continue backing the practices that are positioned to capture growth by investing more in talent and bringing on additional consultants. We also took the opportunity to refine our service portfolio by restructuring the consulting team in select parts of the firm.

Paul A. Maleh executive
#3

During this quarter, those optimization efforts impacted 22 individuals across about six practices located within various corporate functions, resulting in a restructuring charge of $2.6 million. If we break that down, $1.6 million represented cash charges, and $1.0 million was non-cash. We anticipate this action will yield annual cost savings of roughly $5 million, with minimal impact on revenue going forward. It's worth mentioning: we continue to see abundant growth opportunities, and our talent acquisition pipeline remains strong. Our intention is to reinvest those annual savings into the business, making the company stronger and pursuing profitable growth in the quarters ahead. That represents a 4.8% increase — $4.8 million, or 53% year-over-year. Now, turning to guidance. For fiscal 2026, we are reaffirming the full year financial guidance we provided earlier. The strong start to the year, favorable market trends, and our sales pipeline continuing to replenish all give us encouragement; simultaneously, we remain aware that changing geopolitical, global macroeconomic, and business conditions might affect our business. Finally, I hadn't planned to address directly how AI impacts CRA's business and the services we provide, since I think our results speak for themselves — we keep growing revenue, and growing it profitably. Demand for CRA's services is very strong, possibly the strongest I've seen in all my time at CRA. That said, the market for CRA shares seems to indicate a fundamental misunderstanding of what CRA does. Clients engage us because they encounter situations where expert insights can have profound financial and strategic impact. Often, the value at stake for our clients equals many, many multiples of the fees they pay to CRA. Our value stems from expert judgment, framing the right question, selecting defensible assumptions, and supporting conclusions in a business climate that keeps changing and growing more complex. AI can accelerate our work and in many cases enhance it, yet it does not replace CRA's expertise and credibility in complex, high-stakes environments. As we mentioned on our last earnings call, we see AI as both a demand amplifier and a productivity enhancer. Beyond that, we believe it strengthens CRA's overall position thanks to our deep expertise, strong governance, and established credibility; we remain extremely confident about CRA's future and look forward to delivering long-term value to our colleagues, clients, and shareholders in the years ahead. With that, I'll hand the call to Chad and then to Eric for a few additional comments. Chad?

Chad M. Holmes executive
#4

Appreciate it, Paul. Hi, everybody. I'd like to bring you up to speed on our capital position and how we deployed it over the quarter. In the first quarter of 2026, we had net cash outlays of $62.3 million for investments in talent. Roughly 1/4 of that figure went toward bringing in senior revenue-generating talent. About one-half covered performance awards that previously acquired talent had earned under the terms of their original transactions. The other 1/4 was tied to retaining talent. Over the first quarter, we returned $25.3 million in capital to shareholders, made up of $3.8 million in dividend payments plus $21.5 million used to repurchase about 116,000 shares. That shows the ongoing strong confidence the Board and Management have in this business's ability to generate cash and in the company's fundamental worth compared with where the stock currently trades; at present, $44.5 million remains available to us under our share repurchase program. Also during the quarter, we laid out $2.6 million on traditional capital expenditures. We closed out the quarter holding $32.5 million in cash alongside $192 million of borrowings drawn on our revolving credit facility, which left us with net debt of $159.5 million. Keep in mind that borrowing tends to run high in the first quarter, partly because we need to fund annual bonus payments, and that matches how we've handled things in earlier years. Over 80% of the bonuses tied to FY 2025 were paid out during the first quarter, and we expect the last installments to wrap up by the close of the second quarter. We ended the first quarter of fiscal 2026 with total liquidity of $86.7 million, which is $32.5 million in cash and cash equivalents plus another $54.2 million of capacity available on our line of credit. With CRA's annual revenues nearing $800 million, we've grown beyond the current revolving credit facility that was put in place in 2022, back when CRA's revenue was under $600 million. As we laid out in the quarterly report on Form 10-Q filed with the SEC today, earlier this week the company raised its credit facility by $50 million, lifting the aggregate borrowing capacity from $250 million to $300 million. This larger facility gives us financial flexibility to back CRA's ongoing growth and working capital requirements. With that said, I'll hand things over to Eric for some closing remarks. Eric?

Eric Nierenberg executive
#5

Appreciate that, Chad. Just a note that a fuller discussion of our financial results can be found under Prepared CFO Remarks in the investor relations area of our site. Ahead of taking questions, I'd like to share some extra figures tied to how we performed during the first quarter of fiscal 2026. On consultant headcount, we finished the quarter with 971 people, made up of 170 officers, 598 other senior staff, and 203 junior staff. That's a 2.5% rise versus a year earlier, when the count was 947 at the close of Q1 fiscal 2025, and up 1.3% sequentially from the 959 reported at the end of Q4 fiscal 2025. Non-GAAP selling general and administrative expenses, once you set aside the 1.5% tied to commissions paid to non-employee experts, came to 15.6% of revenue in the first quarter of fiscal 2026, versus 15.9% during the same period last year. Our effective tax rate for the first quarter of fiscal 2026, on a non-GAAP basis, was 30.3%, against 27.2% on a non-GAAP basis in the first quarter of fiscal 2025. That climb stems mainly from higher non-deductible executive compensation along with a smaller benefit from share-based compensation. Moving to the balance sheet, DSO came in at 100 days when the first quarter ended, down from 108 days at the close of the fourth quarter of fiscal 2025. DSO for the first quarter broke down as 58 days billed and 42 days unbilled. That wraps up our prepared remarks. We're ready now to take your questions. Rob, go ahead.

Kevin Steinke analyst
#6

Thanks a lot, and hello everyone.

Paul A. Maleh executive
#7

Good morning to you, Kevin.

Kevin Steinke analyst
#8

I'd like to kick things off with a question about how demand is shaping up. Paul, as you mentioned, this may be the most robust you've witnessed since you joined the company. Clearly, your firm has excelled at matching its offerings to what the market requires and is asking for. That surely plays a part in the demand patterns you're observing. Beyond that, is there anything specific in the broader economic backdrop that's genuinely fueling this demand? Case filings and court judgments, you know, keep climbing seemingly faster than the usual pace. The flow of project leads and growth in origination, obviously, remains extremely robust. I'm not sure whether you have further reflections on the favorable market forces you're witnessing given macroeconomic uncertainty.

Paul A. Maleh executive
#9

Yeah. I believe you handled that question quite well. It's somewhat a combination of many factors. I don't want to overlook something. A great deal of it stems from how capable my colleagues are and the work they deliver. Each quarter, each year, we're setting fresh all-time peaks in revenue and profitability, and alongside those fresh financial peaks come fresh peaks in terms of the opportunities and our capacity to turn those opportunities into revenue. That being said, the past five or six months have come at a pace beyond what I've seen. It's distributed fairly normally in relation to the revenue of our practices at CRA. Competitors keep capturing their portion of the biggest cases. We're finding Forensic to be quite busy, along with Life sciences, Energy, and Finance. When roughly 98% of the revenue CRA generates from those eight practices climbs year-over-year by more than 10% from record levels in the prior quarter, that means something. I wish I could identify a single factor, Kevin. The world isn't becoming simpler — it's growing more complicated, and so the demand for that type of expertise in what we offer keeps expanding. Fingers crossed that this carries on through Q2 and the remainder of 2026.

Kevin Steinke analyst
#10

All right, that's excellent. You brought up that their life sciences is expanding at a double-digit rate, which was good to observe. Is there anything specific happening in the marketplace for what you offer that is assisting in driving that expansion, and what's your outlook for that practice moving ahead?

Paul A. Maleh executive
#11

Yes. I believe I've been especially demanding when it comes to Life Sciences. Each quarter I receive inquiries regarding how they're growing, and I've stated, I continue to respond that I'd want to witness a pattern. Well, they have come through with a pattern. At this point they have several quarters of meaningful growth. Their growth hit double digits in this year; we pointed out that our European operations expanded by over 20%, and that resulted from over 20% growth in our European Life Sciences practice along with over 20% growth in our Antitrust & Competition Economics practice. They're receiving fantastic opportunities, and they're turning those opportunities into results. The lead flow is quite strong, not only for the firm, but for the practice specifically. With luck, in Q2 we'll be able to report yet another robust growth figure for that practice.

Kevin Steinke analyst
#12

All right, that's helpful. I also wanted to ask about something you brought up — a strong pipeline when it comes to acquisition talent. Could you expand on what's driving that? And from a numerical standpoint, whenever you put together the 2026 guidance, do you include extra amortization tied to forgivable loans from hiring that happens across this year? Given such a strong pipeline for acquisitions, my assumption is that maybe some amount related to that is already reflected in the guidance.

Paul A. Maleh executive
#13

When it comes to the revenue line in our guidance — regarding revenue, my approach is to consider the colleagues already on board at the moment I give that guidance. Nothing for anticipated inorganic revenue contributions during 2026 gets factored in by me. What I do factor into the profitability margin is certain acquisition costs, or the amortization tied to many of those costs, within the EBITDA profit guidance. My reasoning for not doing the same thing on the revenue side is that the timing of these individuals' arrival and how quickly they can ramp within a particular year is highly uncertain. So the revenue benefit isn't something we assume, yet we do attempt to assume the cost burden that comes with those additions.

Kevin Steinke analyst
#14

All right, that's clear, and it helps. I'll hand it back over. Nice work on the strong results.

Paul A. Maleh executive
#15

Thanks, Kevin.

Marc Riddick analyst
#16

Hey, good morning.

Paul A. Maleh executive
#17

Morning, Marc.

Marc Riddick analyst
#18

I'd like to begin by noting, once again, that the top line growth has been extremely robust and broad-based, just as it has been for a number of quarters. I was hoping to hear a bit more from you regarding your remarks on certain assignment changes. Could you perhaps go into a little more detail on that, and is this something you might expect to do with greater frequency when it comes to talent, as you attempt to align the opportunities that lie ahead? I have a follow-up on that point.

Paul A. Maleh executive
#19

I'm not entirely certain. I missed part of what you asked. Let me begin speaking, then I'll stop so you can clarify something for me. To begin, I appreciate that you acknowledged the top line growth. What I don't want overlooked is that the profit margin is quite impressive, all right? We reported 11.5% on that, compared with what I believe at that moment was nearly a record for first quarter profitability in Q1 of 2025. The cause of the reported decline in EBITDA margin is that rise in forgivable loan amortization. We moved from roughly 5% of revenue, in 2025 for forgivable loan amortization, to 6.9% of revenue in Q1 of fiscal 2026. If you combine the EBITDA with the forgivable loan amortization and set them side by side year-over-year, the reality is the margin differs by no more than 20 basis points. Once more, that's a comparison against record levels. The top line revenue is impressive. My congratulations go out to my colleagues, yet we also must not overlook the robust profitability that has been achieved. As for recruitment, at this time it keeps seeking out the finest talent available. When I have, you know, eight practices generating top-line growth. Many reaching record levels, many reaching double-digit revenue growth. We are not hesitant to bring in talent at any of those units. The people we were fortunate to bring aboard in fiscal 2025 are delivering beyond what we expected as we enter the first quarter of 2026. I expect they will keep ramping up, and Chad has been extremely occupied with recruiting personnel, both throughout the legal regulatory space and on the management consulting side.

Marc Riddick analyst
#20

All right, that's good. My apologies if I dropped off for a moment there. I was hoping to discuss something briefly.

Paul A. Maleh executive
#21

No, that one's on me.

Marc Riddick analyst
#22

I also wanted to spend a moment on how utilization has been getting better. Could you perhaps walk us through how that unfolded across the quarter, and based on what you've said, it sounds like the trend has carried on past the quarter's close — but maybe you could describe that lift in utilization and roughly how it moved during those three months.

Paul A. Maleh executive
#23

Starting in January, we've essentially been sitting in the upper 70s, right around that 70% level. It wasn't a case of steady gains as the quarter went along. Coming into 2026, we were already quite solid right out of the gate. The better utilization showed up not only in legal regulatory, but on the management consulting side of the business too. When everybody is billing additional hours, that produces the top-line growth we talked about. Looking at the medium and long term, our guidance calls for landing in that upper 70s ballpark ahead; combined with tight control of costs, that ought to deliver strong profitability, and profitability that turns into high levels of cash flow, just as it has in the past and will going forward.

Marc Riddick analyst
#24

Thanks. I'd like to spend a moment on something—I believe you mentioned it briefly during your prepared remarks—but could you talk about some of the shifts you've observed when it comes to the degree of complexity, especially involving M&A? In other words, do you get the impression that these deals are stretching out longer? Is it simply a question of, well, what are we noticing compared with, say, 2 or 3 years back in terms of M&A activity and what you're observing in that area?

Paul A. Maleh executive
#25

Yes. I haven't been actively involved in a case for some time now, so pardon me for speaking in general terms about it. The volume of information we're being asked to examine, along with how intricate the markets our clients operate in have become, keeps widening and growing more complicated, and the demand for outcomes delivered as quickly as feasible has never been greater; this applies throughout every one of our business units; it isn't limited to the Antitrust & Competition Economics practice. The Life Sciences practice is going through the same thing. We attempt to call attention to that through the case example involving Most Favored Nation pricing that's underway and the difficulties of launching new drugs with that extra complication involved. We've frequently discussed the Energy practice and what its clients confront given how quickly these data centers are expanding. I honestly can't identify a single practice where things are becoming less complicated. Fortunately for CRA and fortunately for our clients, we possess the right expertise to handle that.

Marc Riddick analyst
#26

That's great, thanks a lot.

Paul A. Maleh executive
#27

Thanks, Marc.

Andrew Nicholas analyst
#28

Hi, good morning.

Paul A. Maleh executive
#29

Good morning, Andrew.

Andrew Nicholas analyst
#30

Hi Paul. I've just got the one question. Most of what I was going to ask has come up already, but I wanted to touch on rate realization and pricing. Clearly, the top-line growth is strong, and I'd assume that plays into it. Could you talk about pricing realization, and then, building on what you were just saying, how much do you think greater complexity and larger projects might help that piece of the growth equation down the road? Thanks.

Paul A. Maleh executive
#31

Absolutely. As in most years, early on we put the market to the test and evaluate whether bill rates should go up across our practices. Our reported rates, on average, see a low to mid-single digit increase. Frequently, during the first quarter, those rate increases contribute very little, since typically the new rates don't help us on legacy projects already underway — the benefit tends to come instead from new projects walking in the door. As the year moves along, those rate increases ought to contribute even more. That said, I'm not claiming the first quarter of 2026 saw no gain from rate increases; it's just that those gains were more likely tied to increases put in place during 2025. I believe once we reach Q2, Q3 and past that, you'll observe a fuller benefit from the rate increases. The early signs look pretty encouraging. We have, you know, always been a high-cost provider of services, correct? What makes that work for CRA, and work for our clients, is that we're also a provider of services with high value added. I think that balance holds; we haven't observed any rise in write-offs on bills going out, though after another quarter or two I can give you a firmer answer. Things look good on that front so far, Andrew.

Andrew Nicholas analyst
#32

Thanks a lot.

Paul A. Maleh executive
#33

Wonderful. Thanks, Rob. To everyone who came on today, I want to say thank you. Your interest in CRA means a lot to us, as does the backing you've given this company throughout the years; during the months ahead, we'll be taking part in conferences and meetings with investors, and we're eager to bring you up to speed on how things are going when we hold our second quarter call. That wraps up today's call. Thank you.

Operator operator
#34

That brings us to the end of today's call. At this point you're free to hang up, and we appreciate your joining us.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete CRA International, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to CRA International, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.